10. The fee for a decentralised application for a marketing authorisation for an immunological product where the United Kingdom is the reference member State is the same as for a national application set out in the previous table, with the addition of the fees in the following table—
| Application | Additional fee (£) |
|---|---|
| One member State | 3,470 |
| Each additional member State | 530 |
| Simultaneous applications: fee for each additional product in the application | |
| 6,670 |
| 120 |